Febrile Neutropenia: Initial Management

Febrile Neutropenia: Initial Management: overview

This algorithm covers the first hours and days of febrile neutropenia: a single temperature of 38.3 C or 38.0 C sustained for one hour, with an absolute neutrophil count under 500 or expected to fall below 500. It is an emergency, so every patient gets blood cultures and empiric intravenous antibiotics within 60 minutes.

Risk is stratified with the MASCC score. Low-risk patients (score 21 or higher) who are stable and have reliable follow-up can be treated as outpatients with oral ciprofloxacin plus amoxicillin-clavulanate after a period of observation. High-risk patients are admitted and receive an antipseudomonal beta-lactam alone, such as cefepime, piperacillin-tazobactam or meropenem. Vancomycin is added only for specific triggers: hemodynamic instability, suspected catheter or skin infection, pneumonia, or known MRSA colonization. If fever persists for four to seven days in a high-risk patient, the workup includes CT chest and galactomannan, and empiric or preemptive mold-active antifungal therapy is started. Antibiotics can stop once the patient is afebrile and the neutrophil count recovers, or after 72 hours afebrile in a stable patient, unless a documented infection needs a full course. G-CSF is not routine for established febrile neutropenia. No specific trials are linked to this chart.

Background reading: Infections in Cancer Patients board review notes.

Febrile Neutropenia: Initial Management: the algorithm in words

Risk stratification, empiric antibiotics and escalation. Starting point: Fever 38.3 C (or 38.0 x 1 h) + ANC under 500 (or expected under 500). Full background: Infections in Cancer Patients notes.

Everyone, within 1 hour (first-line): Do first: Cultures, then empiric IV antibiotics (door to antibiotic 60 minutes or less).
Low risk (MASCC 21+) (first-line): Outpatient eligible: Oral ciprofloxacin + amox-clav (after observation; reliable follow-up).
High risk (MASCC < 21) (first-line): Inpatient: Antipseudomonal beta-lactam alone (cefepime, piperacillin-tazobactam or meropenem).
Add vancomycin if (first-line): Specific triggers: Gram-positive coverage (unstable, catheter or skin infection, pneumonia, MRSA).
Fever persists 4-7 days (first-line): High-risk patient: Empiric or preemptive antifungal (CT chest, galactomannan; mold-active agent).
Duration (first-line): De-escalate: Stop when afebrile and ANC 500+ (or after 72 h afebrile if stable (ECIL)).

Simplified board-prep scaffold; verify against current guidelines (IDSA, ASCO, NCCN). Febrile neutropenia is an emergency: draw blood cultures (peripheral and each catheter lumen) and give antibiotics within 60 minutes. Risk stratify with the MASCC score (21 or higher = low risk) or CISNE in solid tumors. G-CSF is not routine for established febrile neutropenia but can be considered in high-risk patients (sepsis, expected prolonged profound neutropenia).